NewSpring

NewSpring is a prominent multi-strategy private equity firm headquartered in Radnor, Pennsylvania. Established with a focus on delivering flexible capital solutions, the firm manages over $4.0 billion in capital across its diverse investment platforms. NewSpring's approach is characterized by its ability to cater to a wide range of company needs, from growth equity to buyouts, primarily targeting the lower middle-market.

The firm operates through several specialized funds, each with a distinct investment mandate. NewSpring Growth Equity and NewSpring Healthcare both focus on providing capital to high-growth companies, with a particular emphasis on technology-enabled businesses, healthcare services, healthcare IT, and medical device sectors. These funds typically commit initial investments ranging from $10 million to $50 million, aiming to support expansion, market penetration, and strategic initiatives.

Complementing these, NewSpring Mezzanine offers flexible debt solutions, also targeting investments between $10 million and $50 million for companies seeking growth capital or recapitalization. For more mature, profitable businesses, NewSpring Buyout provides significant equity capital, with typical check sizes ranging from $20 million to $100 million, facilitating ownership transitions or strategic acquisitions. Across its strategies, NewSpring has invested in over 185 companies, demonstrating a broad and active portfolio.

NewSpring positions itself as a strategic partner, offering not just capital but also operational expertise and network access to its portfolio companies. Their comprehensive suite of investment products allows them to support businesses at various stages of their lifecycle within the lower middle-market, from rapid growth to mature buyouts, making them a versatile and impactful investor in the private equity landscape.